Breyanzi for car t
Ended Awarded Last action
- Contract number
- 36C24926F0059
- Awardee
-
Bristol-Myers Squibb Company UEI UFGKB2B71N12
- Awarding agency
-
Veterans Integrated Service Network 9
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $335,043
Award facts
- Contract value 100% obligated
- $335,042.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Lawrenceville, Lawrence Township, NJ 08648, USA
Award details come from SAM.gov/FPDS.
About this award
Bristol-Myers Squibb Company has been awarded a delivery order valued at $335,042.65 for the supply of BREYANZI, a chimeric antigen receptor (CAR) T cell therapy used in cancer treatment. The contract was awarded on December 15, 2025, by Veterans Integrated Service Network 9, a civilian agency within the Department of Veterans Affairs, with an ultimate completion date of February 15, 2026. The delivery order is firm fixed-price with no set-aside designation and will be performed at Bristol-Myers Squibb's facility in Lawrenceville, New Jersey.
This delivery order represents a child contract issued under Bristol-Myers Squibb's existing Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB), which carries a substantial ceiling value of approximately $12.3 billion and extends through April 30, 2029. The VA utilizes this multiple-award GSA schedule to procure advanced oncology and immunotherapy treatments for eligible veterans. BREYANZI is indicated for treating non-Hodgkin lymphoma and represents part of Bristol-Myers Squibb's portfolio of specialized cell therapies that support the VA's mission to deliver cutting-edge medical care across its healthcare system.
Quick answers
Who was awarded contract 36C24926F0059?
36C24926F0059 was awarded to Bristol-Myers Squibb Company by Veterans Integrated Service Network 9 (Veterans Health Administration) on December 15, 2025.
How much is contract 36C24926F0059 worth?
The government has obligated $335,043 on 36C24926F0059.
Is contract 36C24926F0059 an order under another contract?
Yes. 36C24926F0059 is a delivery order under 36F79724D0101, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24926F0059 competed?
The extent of competition for 36C24926F0059 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award